114 related articles for article (PubMed ID: 21477558)
21. Temozolomide chemoresistance heterogeneity in melanoma with different treatment regimens: DNA damage accumulation contribution.
Boeckmann L; Nickel AC; Kuschal C; Schaefer A; Thoms KM; Schön MP; Thomale J; Emmert S
Melanoma Res; 2011 Jun; 21(3):206-16. PubMed ID: 21460749
[TBL] [Abstract][Full Text] [Related]
22. microRNA-134 inhibits melanoma growth and metastasis by negatively regulating collagen triple helix repeat containing-1 (CTHRC1).
Li Y; Fu Y; Gao Y; Li H; Ma L; Shu C; Li N; Ma C
Int J Clin Exp Pathol; 2018; 11(9):4319-4330. PubMed ID: 31949828
[TBL] [Abstract][Full Text] [Related]
23. The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling.
LeClair R; Lindner V
Trends Cardiovasc Med; 2007 Aug; 17(6):202-5. PubMed ID: 17662915
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells.
Nummela P; Lammi J; Soikkeli J; Saksela O; Laakkonen P; Hölttä E
Am J Pathol; 2012 Apr; 180(4):1663-74. PubMed ID: 22326753
[TBL] [Abstract][Full Text] [Related]
25. Genomic and molecular profiling predicts response to temozolomide in melanoma.
Augustine CK; Yoo JS; Potti A; Yoshimoto Y; Zipfel PA; Friedman HS; Nevins JR; Ali-Osman F; Tyler DS
Clin Cancer Res; 2009 Jan; 15(2):502-10. PubMed ID: 19147755
[TBL] [Abstract][Full Text] [Related]
26. Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
Pagani E; Falcinelli S; Pepponi R; Turriziani M; Caporaso P; Caporali S; Bonmassar E; D'Atri S
Int J Oncol; 2007 Feb; 30(2):443-51. PubMed ID: 17203227
[TBL] [Abstract][Full Text] [Related]
27. Cthrc1 is a negative regulator of myelination in Schwann cells.
Apra C; Richard L; Coulpier F; Blugeon C; Gilardi-Hebenstreit P; Vallat JM; Lindner V; Charnay P; Decker L
Glia; 2012 Mar; 60(3):393-403. PubMed ID: 22379615
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of ectopically expressed L-plastin enhances invasiveness of human melanoma cells.
Klemke M; Rafael MT; Wabnitz GH; Weschenfelder T; Konstandin MH; Garbi N; Autschbach F; Hartschuh W; Samstag Y
Int J Cancer; 2007 Jun; 120(12):2590-9. PubMed ID: 17290393
[TBL] [Abstract][Full Text] [Related]
29. Dynamic Evolution of the Cthrc1 Genes, a Newly Defined Collagen-Like Family.
Leclère L; Nir TS; Bazarsky M; Braitbard M; Schneidman-Duhovny D; Gat U
Genome Biol Evol; 2020 Feb; 12(2):3957-3970. PubMed ID: 32022859
[TBL] [Abstract][Full Text] [Related]
30. Role of collagen triple helix repeat containing-1 in tumor and inflammatory diseases.
Wu Q; Yang Q; Sun H
J Cancer Res Ther; 2017; 13(4):621-624. PubMed ID: 28901303
[TBL] [Abstract][Full Text] [Related]
31. Collagen triple helix repeat containing 1 promotes endometrial cancer cell migration by activating the focal adhesion kinase signaling pathway.
Hu X; Bian Y; Wen X; Wang M; Li Y; Wan X
Exp Ther Med; 2020 Aug; 20(2):1405-1414. PubMed ID: 32742375
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide.
Sinnberg T; Lasithiotakis K; Niessner H; Schittek B; Flaherty KT; Kulms D; Maczey E; Campos M; Gogel J; Garbe C; Meier F
J Invest Dermatol; 2009 Jun; 129(6):1500-15. PubMed ID: 19078992
[TBL] [Abstract][Full Text] [Related]
33. The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound.
Caporali S; Alvino E; Starace G; Ciomei M; Brasca MG; Levati L; Garbin A; Castiglia D; Covaciu C; Bonmassar E; D'Atri S
Pharmacol Res; 2010 May; 61(5):437-48. PubMed ID: 20026273
[TBL] [Abstract][Full Text] [Related]
34. Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells.
Risberg K; Fodstad O; Andersson Y
J Immunother; 2010 Apr; 33(3):272-8. PubMed ID: 20445347
[TBL] [Abstract][Full Text] [Related]
35. CTHRC1 promotes angiogenesis by recruiting Tie2-expressing monocytes to pancreatic tumors.
Lee J; Song J; Kwon ES; Jo S; Kang MK; Kim YJ; Hwang Y; Bae H; Kang TH; Chang S; Cho HJ; Kim SC; Kim S; Koh SS
Exp Mol Med; 2016 Sep; 48(9):e261. PubMed ID: 27686285
[TBL] [Abstract][Full Text] [Related]
36. Dacarbazine promotes stromal remodeling and lymphocyte infiltration in cutaneous melanoma lesions.
Nardin A; Wong WC; Tow C; Molina TJ; Tissier F; Audebourg A; Garcette M; Caignard A; Avril MF; Abastado JP; Prévost-Blondel A
J Invest Dermatol; 2011 Sep; 131(9):1896-905. PubMed ID: 21654834
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication.
Bai L; Zhang W; Tan L; Yang H; Ge M; Zhu C; Zhang R; Cao Y; Chen J; Luo Z; Ho W; Liu F; Wu K; Wu J
J Mol Cell Biol; 2015 Dec; 7(6):543-56. PubMed ID: 26180054
[TBL] [Abstract][Full Text] [Related]
39. [Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
Yin WH; Fan HZ; Sheng JW; Xia HM; Wu YW; Xie P
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):673-5. PubMed ID: 23888454
[TBL] [Abstract][Full Text] [Related]
40. Collagen triple helix repeat containing-1 in the differential diagnosis of dermatofibrosarcoma protuberans and dermatofibroma.
Wang L; Xiang YN; Zhang YH; Tu YT; Chen HX
Br J Dermatol; 2011 Jan; 164(1):135-40. PubMed ID: 20849518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
